Status:
RECRUITING
Variable Immobilization Protocol for Arthroplasty of the Carpometacarpal Joint of the Thumb
Lead Sponsor:
University of Chicago
Conditions:
Thumb Osteoarthritis
Eligibility:
All Genders
40+ years
Phase:
NA
Brief Summary
Thumb carpometacarpal (CMC) osteoarthritis (OA) is common, seen frequently in middle-aged and elderly women. While a variety of surgical treatments have been described with none superior to any other,...
Detailed Description
Thumb CMC OA is common, with radiographic prevalence ranging from 7% to 35% in the literature, with symptomatic OA affecting 2% to 6% of the population. There is predilection for involvement of the no...
Eligibility Criteria
Inclusion
- Age \>= 40 years old
- Patients undergoing arthroplasty of the first CMC joint including:
- Trapeziectomy with LRTI
- Simple Trapeziectomy
- Suspensionplasty (suture vs. APL)
Exclusion
- Patients \< 40 years of age
- Patients who have undergone prior surgical procedures on the thumb base
- Patients with history of prior procedure at the base of thumb, or those with plan for concomitant carpal tunnel release or thumb metacarpophalangeal (MCP) arthrodesis, will be excluded. Concomitant carpal tunnel surgery may skew outcome surveys, and an arthrodesis procedure will warrant a longer length of immobilization following procedure.
- Those undergoing implant arthroplasty
- Patients with a diagnosis of inflammatory arthritis
- Patients with diagnosis of hypermobility syndrome
Key Trial Info
Start Date :
April 19 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 4 2026
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT04828954
Start Date
April 19 2021
End Date
August 4 2026
Last Update
August 7 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Chicago Medicine
Chicago, Illinois, United States, 60637